Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children
- PMID: 3488385
- DOI: 10.1016/s0022-3476(86)80404-8
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children
Abstract
To evaluate the efficacy of early treatment with erythromycin on the duration of fecal excretion and of diarrhea associated with Campylobacter jejuni, 170 patients, age 3 to 60 months, were randomly assigned in a double-blind fashion to receive either erythromycin ethyl succinate or placebo immediately after being seen at Cayetano Heredia Hospital because of acute dysentery. The groups' pretreatment characteristics were comparable. Of the 30 patients with stools positive for C. jejuni, 12 were in the placebo group and 16 in the treatment group. After 2 days of treatment, none of the patients in the placebo group and 36% of those in the erythromycin group had normal stools (P less than 0.05). After 5 days of treatment, 50% of the patients in the placebo group and 93% of those in the erythromycin group had normal stools (P less than 0.02). Fecal excretion of the organism continued significantly longer in the placebo group (P less than 0.01). There were no treatment failures in the treatment group compared with five (42%) in the placebo group (P less than 0.01). Thus, early administration of erythromycin significantly reduced the duration of both diarrhea and fecal excretion of the organism in infants and children with acute dysentery associated with C. jejuni.
Similar articles
-
Treatment of Campylobacter-associated enteritis with erythromycin.Am J Dis Child. 1983 Mar;137(3):282-5. doi: 10.1001/archpedi.1983.02140290068018. Am J Dis Child. 1983. PMID: 6337473 Clinical Trial.
-
Erythromycin in treatment of Campylobacter enteritis in children.Am J Dis Child. 1983 Mar;137(3):286-8. doi: 10.1001/archpedi.1983.02140290072019. Am J Dis Child. 1983. PMID: 6600579 Clinical Trial.
-
Erythromycin for Campylobacter jejuni-associated dysentery.J Pediatr. 1987 Jul;111(1):161-2. doi: 10.1016/s0022-3476(87)80387-6. J Pediatr. 1987. PMID: 3598790 No abstract available.
-
The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings.PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006200. doi: 10.1371/journal.pntd.0006200. eCollection 2018 Feb. PLoS Negl Trop Dis. 2018. PMID: 29415075 Free PMC article.
-
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.Am J Med. 1985 Jun 28;78(6B):81-90. doi: 10.1016/0002-9343(85)90369-9. Am J Med. 1985. PMID: 3893119 Review.
Cited by
-
Management of infectious diarrhoea.Gut. 2004 Feb;53(2):296-305. doi: 10.1136/gut.2003.022103. Gut. 2004. PMID: 14724167 Free PMC article. Review. No abstract available.
-
Factors that explain excretion of enteric pathogens by persons without diarrhea.Clin Infect Dis. 2012 Dec;55 Suppl 4(Suppl 4):S303-11. doi: 10.1093/cid/cis789. Clin Infect Dis. 2012. PMID: 23169942 Free PMC article.
-
Test-of-cure stool cultures for traveler's diarrhea.J Clin Microbiol. 1988 May;26(5):1047-9. doi: 10.1128/jcm.26.5.1047-1049.1988. J Clin Microbiol. 1988. PMID: 3290233 Free PMC article. Clinical Trial.
-
A Historical Review on Antibiotic Resistance of Foodborne Campylobacter.Front Microbiol. 2019 Jul 26;10:1509. doi: 10.3389/fmicb.2019.01509. eCollection 2019. Front Microbiol. 2019. PMID: 31402900 Free PMC article. Review.
-
Symptomatic and Asymptomatic Campylobacter Infections and Child Growth in South Asia: Analyzing Data from the Global Enteric Multicenter Study.Am J Trop Med Hyg. 2023 May 1;108(6):1204-1211. doi: 10.4269/ajtmh.22-0347. Print 2023 Jun 7. Am J Trop Med Hyg. 2023. PMID: 37127268 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical